2025 annual financial data
BioRestorative Therapies 2025 Net margin
Direct answer
Net margin was -3,959.4%.
Operating income was -15,647,132 USD and net income was -14,241,975 USD.
Operating cash flow was -10,788,963 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 359,700 USD
- Operating income
- -15,647,132 USD
- Net income
- -14,241,975 USD
- Operating cash flow
- -10,788,963 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all BioRestorative Therapies financial years